Topical Cannabinoid and Brassinosteroid Compositions for Skin Infections
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bacterial and fungal skin infections are inadequate in effectively reducing symptoms and eliminating microbial infections, particularly those caused by Staphylococci, Streptococci, and fungi like Aspergillus, due to limitations in antimicrobial efficacy and speed of action.
Innovation Solution
The development of antimicrobial compositions incorporating cannabinoids, such as cannabidiol and cannabigerol, combined with brassinosteroids, which are administered topically to provide enhanced antimicrobial activity, reduce toxin production, and improve skin condition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current antimicrobial treatments are used, then some microbial infection symptoms are treated, but the treatments are inadequate in effectively reducing symptoms and eliminating microbial infections
Solution Approach 1:
The patent combines multiple cannabinoids (CBD, CBG, CBC, CBN) with brassinosteroids in a single topical composition to achieve synergistic antimicrobial effects. This merging of multiple active ingredients addresses the inadequacy of single-agent treatments by creating a multi-component formulation that targets various aspects of microbial infection simultaneously, thereby improving both reliability and speed of action.
Solution Approach 2:
The invention creates a composite antimicrobial composition integrating cannabinoids and brassinosteroids. This composite material approach allows the formulation to leverage the unique properties of each component class - the antimicrobial and anti-inflammatory effects of cannabinoids combined with the growth-promoting and healing-enhancing properties of brassinosteroids, resulting in a treatment that overcomes the limitations of conventional single-mechanism antimicrobials.
2Reliability
If single-component antimicrobial treatments are used, then treatment simplicity is maintained, but efficacy is insufficient
Solution Approach 1:
The patent merges multiple naturally occurring compounds (cannabinoids and brassinosteroids) into a single integrated topical composition. While the composition contains multiple active ingredients, they are formulated together as one unified product, maintaining ease of application while achieving superior efficacy through the synergistic interaction of the combined components.
Solution Approach 2:
The multi-component composition is designed to perform multiple functions simultaneously: antimicrobial action, anti-inflammatory effects, toxin reduction, and skin healing promotion. This universal approach allows a single treatment to address various aspects of skin infections and inflammatory conditions, making the slightly more complex composition highly versatile and effective for multiple dermatological issues.
Data Source
AI summary
Embodiments of the invention are directed to compositions containing cannabinoid, cannabidiol, cannabidiol isomer, or cannabidiol analog and combinations thereof for treating microbial infections, and methods for treating microbial infections by topically administering compositions containing cannabinoid, cannabidiol, or cannabidiol analog to the patient in need of treatment.